Evidence map›Paper›PMID 42182509›Full record

ArticlebioRxiv : the preprint server for biology2026

Yoda molecules agonize PIEZO2.

Tharaka D Wijerathne, Aneesh Chandrasekharan, Aashish Bhatt, Yun L Luo, Jérôme J Lacroix

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tharaka D WijerathneDepartment of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Aneesh ChandrasekharanDepartment of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Aashish BhattDepartment of Biotechnology and Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Yun L LuoDepartment of Biotechnology and Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.ORCID 0000-0003-3581-754X
Jérôme J LacroixDepartment of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA.ORCID 0000-0001-5687-0652

Funding

PHARMACOLOGICAL MODULATION OF PIEZO1 CHANNELSR01GM130834 · NIGMS · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI Yun Lyna LUO, Jerome Lacroix · 2019 to 2026
$2.8M
Breakthrough Molecular Dynamics Research via an Anton 3 SupercomputerR24GM154042 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI Philip D. Blood · 2024 to 2026
$2.3M
Cooperative Modulation of Piezo ChannelsR01HL179692 · NHLBI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI Yun Lyna LUO, Jerome Lacroix · 2025 to 2026
$1.3M
Dynamics and heteromerization of PIEZO channel subunitsR21AT013465 · NCCIH · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI LACROIX, JEROME JACQUES · 2025 to 2025
$391k
NCCIH NIH HHS R21 AT013465NHLBI NIH HHS R01 HL179692NIGMS NIH HHS R01 GM130834NIGMS NIH HHS R24 GM154042
6 · The paper itself

Abstract

PIEZO proteins (PIEZO1 and PIEZO2) are essential mechanosensitive channels. PIEZO1 is thought to be selectively activated by Yoda molecules (Yoda1 and Yoda2). Although a structural framework for PIEZO1 activation by Yoda1 exists, a molecular mechanism underlying this selective activation is lacking. Here, using electrophysiology and calcium imaging, we show that Yoda1 increases PIEZO2 open probability and stretch sensitivity as efficaciously as PIEZO1 but elicits weaker PIEZO2-dependent calcium entry, rationalizing why its effect on PIEZO2 has been overlooked. Both Yoda1 and its more potent Yoda2 analog slow down inactivation of PIEZO2 currents with potency similar to PIEZO1 but with lower efficacy. Using mutagenesis and molecular dynamics simulations, we further show that Yoda2's benzoic acid group forms a transient salt bridge with a conserved arginine in the Yoda binding site, providing a molecular basis for Yoda2's increased potency. Our study cautions a reevaluation of studies using these molecules to untangle biological functions mediated by PIEZO channels.

Indexed as

mechanotransductionPIEZO1PIEZO2Yoda1Yoda2

Identifiers

PMID42182509
PMCPMC13192943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.